| scholarly article | Q13442814 |
| P50 | author | Carlos Juan | Q41183643 |
| Alfonso Navas | Q51725568 | ||
| Jesus Blazquez | Q68273789 | ||
| P2093 | author name string | Antonio Oliver | |
| Laura Zamorano | |||
| Gabriel Cabot | |||
| Bartolomé Moyà | |||
| P2860 | cites work | Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen | Q22122393 |
| Pseudomonas Genome Database: improved comparative analysis and population genomics capability for Pseudomonas genomes | Q24609340 | ||
| Multiple pathways for SOS-induced mutagenesis in Escherichia coli: an overexpression of dinB/dinP results in strongly enhancing mutagenesis in the absence of any exogenous treatment to damage DNA | Q24628966 | ||
| Structural basis for effectiveness of siderophore-conjugated monocarbams against clinically relevant strains of Pseudomonas aeruginosa | Q27666204 | ||
| Pseudomonas aeruginosa: all roads lead to resistance | Q28240246 | ||
| Induction of the MexXY efflux pump in Pseudomonas aeruginosa is dependent on drug-ribosome interaction | Q28492803 | ||
| Pseudomonas aeruginosa galU is required for a complete lipopolysaccharide core and repairs a secondary mutation in a PA103 (serogroup O11) wbpM mutant | Q28492943 | ||
| Genetic determinants involved in the susceptibility of Pseudomonas aeruginosa to beta-lactam antibiotics | Q28493162 | ||
| Defining the Pseudomonas aeruginosa SOS response and its role in the global response to the antibiotic ciprofloxacin | Q29346807 | ||
| An ordered, nonredundant library of Pseudomonas aeruginosa strain PA14 transposon insertion mutants | Q29614860 | ||
| Construction of a mini-Tn5-luxCDABE mutant library in Pseudomonas aeruginosa PAO1: a tool for identifying differentially regulated genes | Q30781626 | ||
| The neglected intrinsic resistome of bacterial pathogens | Q33320525 | ||
| Genomewide identification of genetic determinants of antimicrobial drug resistance in Pseudomonas aeruginosa | Q33424246 | ||
| Inactivation of the hmgA gene of Pseudomonas aeruginosa leads to pyomelanin hyperproduction, stress resistance and increased persistence in chronic lung infection | Q33424268 | ||
| Escherichia coli mutator genes | Q33539352 | ||
| Negative regulation of the Pseudomonas aeruginosa outer membrane porin OprD selective for imipenem and basic amino acids | Q33976208 | ||
| Sequence-verified two-allele transposon mutant library for Pseudomonas aeruginosa PAO1. | Q34415790 | ||
| Characterization of the polymyxin B resistome of Pseudomonas aeruginosa. | Q34446329 | ||
| High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection. | Q34508854 | ||
| Overexpression of AmpC and efflux pumps in Pseudomonas aeruginosa isolates from bloodstream infections: prevalence and impact on resistance in a Spanish multicenter study | Q34932869 | ||
| Evolutionary dynamics of bacteria in a human host environment | Q34937408 | ||
| Antibacterial-resistant Pseudomonas aeruginosa: clinical impact and complex regulation of chromosomally encoded resistance mechanisms | Q35007624 | ||
| Pseudomonas aeruginosa: resistance to the max | Q35084559 | ||
| Nosocomial infections in adult intensive-care units | Q35157647 | ||
| PmrB mutations promote polymyxin resistance of Pseudomonas aeruginosa isolated from colistin-treated cystic fibrosis patients | Q35689189 | ||
| Selective Sweeps and Parallel Pathoadaptation Drive Pseudomonas aeruginosa Evolution in the Cystic Fibrosis Lung | Q35761876 | ||
| Experimental validation of Haldane's hypothesis on the role of infection as an evolutionary force for Metazoans | Q35963009 | ||
| Mutations in β-Lactamase AmpC Increase Resistance of Pseudomonas aeruginosa Isolates to Antipseudomonal Cephalosporins. | Q36075893 | ||
| Pan-β-lactam resistance development in Pseudomonas aeruginosa clinical strains: molecular mechanisms, penicillin-binding protein profiles, and binding affinities | Q36172484 | ||
| Regulation of virulence and antibiotic resistance by two-component regulatory systems in Pseudomonas aeruginosa | Q37401403 | ||
| Pseudomonas genomes: diverse and adaptable | Q37848453 | ||
| Pseudomonas aeruginosa: new insights into pathogenesis and host defenses | Q38101888 | ||
| PBP3 inhibition elicits adaptive responses in Pseudomonas aeruginosa. | Q38309969 | ||
| Antagonistic interactions of Pseudomonas aeruginosa antibiotic resistance mechanisms in planktonic but not biofilm growth. | Q38626934 | ||
| BOCILLIN FL, a sensitive and commercially available reagent for detection of penicillin-binding proteins | Q39470055 | ||
| Overexpression of MexCD-OprJ reduces Pseudomonas aeruginosa virulence by increasing its susceptibility to complement-mediated killing. | Q39683346 | ||
| SOS-independent induction of dinB transcription by beta-lactam-mediated inhibition of cell wall synthesis in Escherichia coli. | Q40943537 | ||
| Pseudomonas aeruginosa ceftolozane-tazobactam resistance development requires multiple mutations leading to overexpression and structural modification of AmpC | Q41075944 | ||
| Genetic markers of widespread extensively drug-resistant Pseudomonas aeruginosa high-risk clones. | Q41183478 | ||
| Genetic adaptation of Pseudomonas aeruginosa to the airways of cystic fibrosis patients is catalyzed by hypermutation | Q41366386 | ||
| Alterations in two-component regulatory systems of phoPQ and pmrAB are associated with polymyxin B resistance in clinical isolates of Pseudomonas aeruginosa | Q41964844 | ||
| A two-component regulatory system interconnects resistance to polymyxins, aminoglycosides, fluoroquinolones, and β-lactams in Pseudomonas aeruginosa. | Q42118850 | ||
| Increased expression of ampC in Pseudomonas aeruginosa mutants selected with ciprofloxacin | Q42131963 | ||
| Biological markers of Pseudomonas aeruginosa epidemic high-risk clones | Q42249771 | ||
| Affinity of the new cephalosporin CXA-101 to penicillin-binding proteins of Pseudomonas aeruginosa | Q42430254 | ||
| Inactivation of the mismatch repair system in Pseudomonas aeruginosa attenuates virulence but favors persistence of oropharyngeal colonization in cystic fibrosis mice. | Q42560500 | ||
| Benefit of having multiple ampD genes for acquiring beta-lactam resistance without losing fitness and virulence in Pseudomonas aeruginosa | Q43189895 | ||
| Deletion and acquisition of genomic content during early stage adaptation of Pseudomonas aeruginosa to a human host environment | Q60451766 | ||
| Development of colistin resistance in pmrA-, phoP-, parR- and cprR-inactivated mutants of Pseudomonas aeruginosa | Q88216913 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Pseudomonas aeruginosa | Q31856 |
| P304 | page(s) | 1767-1778 | |
| P577 | publication date | 2016-01-04 | |
| P1433 | published in | Antimicrobial Agents and Chemotherapy | Q578004 |
| P1476 | title | Evolution of Pseudomonas aeruginosa Antimicrobial Resistance and Fitness under Low and High Mutation Rates | |
| P478 | volume | 60 |
| Q96303543 | A Core Genome Multilocus Sequence Typing Scheme for Pseudomonas aeruginosa |
| Q90387878 | A large-scale whole-genome comparison shows that experimental evolution in response to antibiotics predicts changes in naturally evolved clinical Pseudomonas aeruginosa |
| Q46361258 | Alternative Evolutionary Paths to Bacterial Antibiotic Resistance Cause Distinct Collateral Effects |
| Q91576678 | An Autoinducer Analogue Reveals an Alternative Mode of Ligand Binding for the LasR Quorum-Sensing Receptor |
| Q52685491 | Antibiotic selection in the treatment of acute invasive infections by Pseudomonas aeruginosa: Guidelines by the Spanish Society of Chemotherapy. |
| Q59809260 | Characteristics of Isolated from Bovine Mastitis Exposed to Subminimum Inhibitory Concentrations of Cefalotin or Ceftazidime |
| Q55361255 | Combination antibiotics against Pseudomonas aeruginosa, representing common and rare cystic fibrosis strains from different Irish clinics. |
| Q37428703 | Deciphering the Resistome of the Widespread Pseudomonas aeruginosa Sequence Type 175 International High-Risk Clone through Whole-Genome Sequencing. |
| Q40346786 | Determining β-lactam exposure threshold to suppress resistance development in Gram-negative bacteria |
| Q90148668 | Dynamic Emergence of Mismatch Repair Deficiency Facilitates Rapid Evolution of Ceftazidime-Avibactam Resistance in Pseudomonas aeruginosa Acute Infection |
| Q42089533 | Dynamics of Mutations during Development of Resistance by Pseudomonas aeruginosa against Five Antibiotics |
| Q90230125 | Evaluation of Tobramycin and Ciprofloxacin as a Synergistic Combination Against Hypermutable Pseudomonas Aeruginosa Strains via Mechanism-Based Modelling |
| Q33911762 | Evolution of the Pseudomonas aeruginosa mutational resistome in an international Cystic Fibrosis clone |
| Q45897898 | Evolved Aztreonam Resistance Is Multifactorial and Can Produce Hypervirulence in Pseudomonas aeruginosa |
| Q91720690 | Genomic Analysis Identifies Novel Pseudomonas aeruginosa Resistance Genes under Selection during Inhaled Aztreonam Therapy In Vivo |
| Q40056971 | Genomics and Susceptibility Profiles of Extensively Drug-Resistant (XDR) Pseudomonas aeruginosa from Spain. |
| Q30234118 | Genomics of antibiotic-resistance prediction in Pseudomonas aeruginosa |
| Q38644903 | History of antibiotic adaptation influences microbial evolutionary dynamics during subsequent treatment |
| Q89766030 | Hypermutator Pseudomonas aeruginosa exploits multiple genetic pathways to develop multidrug resistance during long-term infections in the airways of cystic fibrosis patients |
| Q63438192 | Identifying and exploiting genes that potentiate the evolution of antibiotic resistance |
| Q38978571 | Insights into host-pathogen interactions from state-of-the-art animal models of respiratory Pseudomonas aeruginosa infections |
| Q47877807 | Insights into the evolution of the mutational resistome of Pseudomonas aeruginosa in cystic fibrosis |
| Q57158084 | Interplay between Peptidoglycan Biology and Virulence in Gram-Negative Pathogens |
| Q40559371 | Molecular Epidemiology of Mutations in Antimicrobial Resistance Loci of Pseudomonas aeruginosa Isolates from Airways of Cystic Fibrosis Patients |
| Q59135449 | Molecular epidemiology of Pseudomonas aeruginosa in University Clinical Center of Kosovo |
| Q58596095 | Mutational Evolution of Resistance to Ribosome-Targeting Antibiotics |
| Q37538678 | Penicillin-Binding Protein 3 Is Essential for Growth of Pseudomonas aeruginosa |
| Q89671585 | Predicting antimicrobial resistance in Pseudomonas aeruginosa with machine learning-enabled molecular diagnostics |
| Q64065367 | Profiling the susceptibility of Pseudomonas aeruginosa strains from acute and chronic infections to cell-wall-targeting immune proteins |
| Q40696824 | Pyomelanin-producing Pseudomonas aeruginosa selected during chronic infections have a large chromosomal deletion which confers resistance to pyocins |
| Q98613814 | Rapid and robust evolution of collateral sensitivity in Pseudomonas aeruginosa antibiotic-resistant mutants |
| Q61455281 | Resistance to Ceftolozane/Tazobactam in Arising by AmpC- and Non-AmpC-Mediated Pathways |
| Q91846101 | Roles of two-component regulatory systems in antibiotic resistance |
| Q91623019 | The Essential Role of Hypermutation in Rapid Adaptation to Antibiotic Stress |
| Q52313185 | The Versatile Mutational Resistome of Pseudomonas aeruginosa. |
| Q93066662 | The toxin from a ParDE toxin-antitoxin system found in Pseudomonas aeruginosa offers protection to cells challenged with anti-gyrase antibiotics |
| Q98463614 | Transcriptomic determinants of the response of ST-111 Pseudomonas aeruginosa AG1 to ciprofloxacin identified by a top-down systems biology approach |
| Q64059475 | Two Component Regulatory Systems and Antibiotic Resistance in Gram-Negative Pathogens |
| Q91943451 | Vanillin mediated green synthesis and application of gold nanoparticles for reversal of antimicrobial resistance in Pseudomonas aeruginosa clinical isolates |
| Q93049719 | lptG contributes to changes in membrane permeability and the emergence of multidrug hypersusceptibility in a cystic fibrosis isolate of Pseudomonas aeruginosa |
Search more.